Opinion|Videos|June 28, 2024
CLL Treatment Landscape: Overview of BTK Inhibitors
A panel of experts provide an overview of BTK inhibitors for the treatment of patients with chronic lymphocytic leukemia.
Advertisement
Episodes in this series
Video content above is prompted by the following question(s):
- Provide an overview of the current landscape of treatment-naïve CLL treatment options. Where do the BTK inhibitors fit into this landscape?
Advertisement
Related Content
Advertisement
Advertisement
Trending on AJMC
1
Hans Lee, MD, Discusses “Off-the-Shelf” Solution for Rare Blood Disorder With No Approved Therapies
2
ACP Names Semaglutide, Tirzepatide as First-Line Pharmacotherapy for Obesity
3
CMS Proposes Permanent Rules for Medicare Drug Price Negotiation
4
AI Billing, GLP-1s Among Forces Driving 9% Health Cost Spike
5